AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,049 | -5.4% | 406 | +8.3% | 0.00% | – |
| Q2 2023 | $10,620 | +44.0% | 375 | +16.8% | 0.00% | – |
| Q1 2023 | $7,373 | -23.9% | 321 | -7.0% | 0.00% | – |
| Q4 2022 | $9,688 | +7.6% | 345 | +8.5% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 318 | +15.2% | 0.00% | – |
| Q2 2022 | $6,000 | +20.0% | 276 | +65.3% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 167 | +391.2% | 0.00% | – |
| Q4 2021 | $1,000 | – | 34 | +183.3% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 12 | -78.6% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 56 | -5.1% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 59 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $3,000 | -50.0% | 59 | -33.7% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -33.3% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $9,000 | +12.5% | 89 | +3.5% | 0.00% | 0.0% |
| Q1 2015 | $8,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |